Cardiol Therapeutics (CRDL) Q3 2024 Earnings
CRDL·Reported November 14, 2024·Before market open
Diluted EPS came in at $-0.13, missed the $-0.10 consensus by $0.03.
Diluted EPS
$-0.13missed by $0.03
Consensus: $-0.10
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q3 2024 Earnings FAQ
Common questions about Cardiol Therapeutics's Q3 2024 earnings report.
Cardiol Therapeutics (CRDL) reported Q3 2024 earnings on November 14, 2024 before market open.
Cardiol Therapeutics reported diluted EPS of $-0.13 for Q3 2024.
EPS missed the consensus estimate of $-0.10 by $0.03.